Differential response of plasma lipoprotein(a) and apolipoprotein B in NIDDM subjects treated with acarbose.
Hegele
R A
RA
Connelly
P W
PW
Palmason
C
C
Jenkins
D J
DJ
Wolever
T M
TM
D020909:Acarbose; D001055:Apolipoproteins B / Q000097:blood* / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D017270:Lipoprotein(a) / Q000097:blood* / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014312:Trisaccharides / Q000627:therapeutic use*
D020909:Acarbose; D001055:Apolipoproteins B; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D017270:Lipoprotein(a); D014312:Trisaccharides